ILMN

Illumina Inc

Feb 06 • 12:37PM ET

117.77

-15.84 -11.86 %

Healthcare • Diagnostics & Research • USA • NASD

Feb 05, 7:15 PMIllumina reports fiscal Q4 2025 results with non-GAAP EPS $1.35 (+42% YoY) and revenue $1.2B (+5% YoY), beats EPS and revenue estimates, and issues fiscal 2026 guidance

Peers: PACB VRTX TXG QGEN GH BIO MYGN IONS TWST OMIC

| Held by: IJH VTI VB VBR VXF XMHQ MDY IBB SPMD ARKK

Scroll to Statements

Index	-	P/E	21.59	EPS (ttm)	5.45	Insider Own	2.81%	Shs Outstand	152.80M	Perf Week	-18.67%
Market Cap	18.00B	Forward P/E	20.29	EPS next Y	5.80	Insider Trans	-0.01%	Shs Float	148.51M	Perf Month	-21.56%
Enterprise Value	18.84B	PEG	1.85	EPS next Q	1.07	Inst Own	104.76%	Short Float	4.35%	Perf Quarter	-3.81%
Income	850.00M	P/S	4.15	EPS this Y	5.45%	Inst Trans	1.73%	Short Ratio	3.58	Perf Half Y	23.32%
Sales	4.34B	P/B	7.57	EPS next Y	13.71%	ROA	13.13%	Short Interest	6.46M	Perf YTD	-10.21%
Book/sh	15.56	P/C	11.02	EPS next 5Y	10.96%	ROE	33.36%	52W High	155.53 -24.28%	Perf Year	-5.54%
Cash/sh	10.69	P/FCF	18.00	EPS past 3/5Y	- 4.22%	ROIC	18.09%	52W Low	68.70 71.43%	Perf 3Y	-44.03%
Dividend Est.	-	EV/EBITDA	16.18	Sales past 3/5Y	-1.78% 6.04%	Gross Margin	67.07%	Volatility	4.27% 3.90%	Perf 5Y	-72.67%
Dividend TTM	-	EV/Sales	4.34	EPS Y/Y TTM	144.91%	Oper. Margin	20.58%	ATR (14)	6.06	Perf 10Y	-23.28%
Dividend Ex-Date	-	Quick Ratio	1.72	Sales Y/Y TTM	-0.73%	Profit Margin	19.59%	RSI (14)	26.89	Recom	2.52
Dividend Gr. 3/5Y	- -	Current Ratio	2.08	EPS Q/Q	84.80%	SMA20	-18.21%	Beta	1.46	Target Price	136.44
Payout	-	Debt/Eq	0.91	Sales Q/Q	4.98%	SMA50	-14.66%	Rel Volume	2.16	Prev Close	133.61
Employees	10370	LT Debt/Eq	0.73	Earnings	Feb 05 AMC	SMA200	10.20%	Avg Volume	1.80M	Price	117.77
IPO	Jul 28, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	8.70% 3.60%	Trades		Volume	1,971,903	Change	-11.86%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-12-25	Downgrade	Daiwa Securities	Outperform → Neutral	$94
Jul-11-25	Downgrade	Scotiabank	Sector Outperform → Sector Perform	$125
Mar-04-25	Reiterated	Citigroup	Neutral	$130 → $90
Feb-28-25	Downgrade	HSBC Securities	Buy → Hold	$100
Feb-10-25	Downgrade	Barclays	Equal Weight → Underweight	$130 → $100
Feb-07-25	Downgrade	TD Cowen	Buy → Hold	$177 → $140
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$190 → $165
Nov-12-24	Resumed	Morgan Stanley	Equal-Weight	$156
Oct-17-24	Upgrade	HSBC Securities	Hold → Buy	$180
Aug-28-24	Upgrade	Argus	Hold → Buy
Aug-16-24	Upgrade	Daiwa Securities	Neutral → Buy	$120 → $154
Aug-14-24	Upgrade	TD Cowen	Hold → Buy	$126 → $144
Aug-14-24	Upgrade	Barclays	Underweight → Equal Weight	$125
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$140
Jun-03-24	Resumed	Jefferies	Hold	$115
Jan-16-24	Downgrade	HSBC Securities	Buy → Hold
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$144
Dec-18-23	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$185
Dec-15-23	Upgrade	Bernstein	Underperform → Mkt Perform
Dec-14-23	Initiated	Stephens	Overweight	$170

Show Previous Ratings

Today 03:48AM	Analyst Report: Illumina, Inc. (Morningstar Research) -11.86%
12:36AM	ILMN Q4 Deep Dive: Clinical Consumables Growth, Multiomics Expansion, and Margin Momentum (StockStory)
12:05AM	Illumina Inc (ILMN) Q4 2025 Earnings Call Highlights: Strong Clinical Growth Amidst Research ... (GuruFocus.com)
Feb-05-26 08:58PM	Illumina Q4 Earnings Call Highlights (MarketBeat)
07:00PM	Illumina (ILMN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:00PM	Loading…
06:00PM	Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates (Zacks)
04:59PM	Illumina: Q4 Earnings Snapshot (Associated Press Finance)
04:17PM	Illumina (NASDAQ:ILMN) Reports Bullish Q4 CY2025 (StockStory)
04:06PM	Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2025 (PR Newswire)
Feb-04-26 09:15AM	Insights Into Illumina (ILMN) Q4: Wall Street Projections for Key Metrics (Zacks)
Feb-03-26 10:18PM	Illumina (ILMN) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory)
06:15PM	Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
09:15AM	Illumina and the San Diego Zoo Wildlife Alliance partner to sequence the Frozen Zoo, supporting critical conservation genetics efforts globally (PR Newswire)
08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Feb-02-26 09:37AM	ILMN Q4 Earnings Preview: NovaSeq X Momentum Likely to Aid Performance (Zacks)
12:47AM	Loading…
12:47AM	Grail files for FDA approval of multi-cancer early detection test (MedTech Dive)
Jan-30-26 10:00AM	Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:05AM	Illumina completes acquisition of SomaLogic (PR Newswire)
Jan-29-26 10:00AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jan-27-26 08:55AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jan-24-26 12:01PM	The Most Expensive Question Investors Ask (Barchart)
Jan-23-26 11:40AM	REGN or ILMN: Which Is the Better Value Stock Right Now? (Zacks)
Jan-21-26 10:31PM	Life Sciences Tools & Services Stocks Q3 Teardown: Illumina (NASDAQ:ILMN) Vs The Rest (StockStory)
04:58PM	Cathie Wood Has 13 Big Ideas For 2026: Here's The Ark Invest List And Stocks To Watch (Benzinga)
Jan-20-26 01:19PM	Illumina Gets Medicare Boost for Cancer Test, Shares Climb (Benzinga)
09:15AM	Illumina secures CMS reimbursement for TruSight Oncology Comprehensive, expanding access to precision oncology (PR Newswire)
04:58AM	Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside (Insider Monkey)
12:05AM	Cathie Wood's Ark Unleashes Cryptic ARKmoji Teasers To Showcase Its 'Big Ideas' For 2026: Can You Take A Guess At The Hidden Meaning? (Benzinga)
Jan-16-26 02:22AM	The clinical candidates pharma execs are tracking (Pharma Voice)
Jan-15-26 08:55AM	These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
04:58PM	Loading…
Jan-13-26 04:58PM	Illumina CEO Sees Big Growth Opportunity in China (Bloomberg)
01:01PM	JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery (Pharmaceutical Technology)
12:37PM	Analyst Report: Illumina, Inc. (Morningstar Research)
09:15AM	Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery (PR Newswire)
09:00AM	Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 (PR Newswire)
07:30AM	TEM's Collab for Oncology Patient Population Is Gaining Attention (Zacks)
Jan-12-26 04:07PM	Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026 (PR Newswire)
11:34AM	Nvidia, Eli Lilly announce $1 billion investment in AI drug discovery lab (Yahoo Finance)
08:09AM	Illumina's New Connected Multiomics Platform Set to Boost Its Stock (Zacks)
Jan-09-26 12:10PM	Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? (Zacks)
08:55AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Jan-08-26 04:30PM	Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026 (Business Wire)
04:30PM	Illumina Appoints Dr. Eric Green as Chief Medical Officer (PR Newswire)
Jan-07-26 11:40AM	REGN vs. ILMN: Which Stock Is the Better Value Option? (Zacks)
07:33AM	TEM's Stable Solvency and Financial Strength Are Gaining Attention (Zacks)
Jan-06-26 07:48PM	Analyst Report: Illumina, Inc. (Morningstar Research)
11:40AM	REGN vs. ILMN: Which Stock Should Value Investors Buy Now? (Zacks)
09:15AM	Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis (PR Newswire)
07:06AM	Three Genomics Stocks Worth Tracking This Year (Zacks)
Jan-02-26 07:35AM	Is This the Right Time to Add PBH Stock to Your Portfolio? (Zacks)
Dec-31-25 09:50AM	Here's Why Illumina (ILMN) is a Strong Momentum Stock (Zacks)
01:30AM	It's Earnings Warning Season. How to Profit From Others' Misery. (Barrons.com)
Dec-30-25 08:06AM	Should Myriad Genetics Stock Stay in Your Portfolio Right Now? (Zacks)
07:32AM	Should You Continue to Hold EXAS Stock in Your Portfolio Now? (Zacks)
Dec-26-25 07:49AM	Should You Continue to Hold BRKR Stock in Your Portfolio? (Zacks)
07:18AM	How Tempus AI Is Advancing Toward Regulatory Pricing Catch-Up (Zacks)
07:17AM	Reasons to Retain Penumbra Stock in Your Portfolio for Now (Zacks)
Dec-24-25 08:36AM	Is Quest Diagnostics Stock a Right Pick for Your Portfolio Now? (Zacks)
Dec-23-25 02:08PM	Is This the Right Time to Add Veracyte Stock to Your Portfolio? (Zacks)
02:08PM	Abbott Stock May Benefit Following Volt PFA's FDA Approval (Zacks)
Dec-22-25 07:49AM	TMO Stock May Benefit From PPD CorEvitas Alzheimer's Registry Launch (Zacks)
07:11AM	Illumina (ILMN) Surges 3.3%: Is This an Indication of Further Gains? (Zacks)
Dec-19-25 09:09AM	National Vision Stock Surges 154.6% in a Year: What's Driving it? (Zacks)
Dec-18-25 08:36AM	Should You Continue to Hold CRL Stock in Your Portfolio for Now? (Zacks)
07:45AM	Should Investors Hold Chemed Stock in Their Portfolio Now? (Zacks)
Dec-17-25 10:14AM	Can These 5 Relative Price Strength Stocks Lead in 2026? (Zacks)
07:58AM	How the OneStep Partnership Could Drive Growth for ZBH Stock (Zacks)
07:55AM	Should You Retain Teleflex Stock in Your Portfolio Now? (Zacks)
Dec-16-25 04:05PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
07:58AM	Is Phibro Animal Health Stock a Smart Addition to Your Portfolio Now? (Zacks)
07:47AM	TMO Stock Set to Gain From the Expansion of Gibco Bacto Portfolio (Zacks)
Dec-15-25 09:12AM	CVS Stock Gains From Offering MMR Vaccine to South Carolina Residents (Zacks)
Dec-12-25 09:50AM	Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term (Zacks)
07:11AM	Is it Apt to Retain Haemonetics Stock in Your Portfolio Now? (Zacks)
Dec-11-25 09:15AM	Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually (PR Newswire)
08:09AM	Should You Continue to Hold EW Stock in Your Portfolio? (Zacks)
Dec-10-25 08:34AM	Is it Worth Retaining NEOG Stock in Your Portfolio for Now? (Zacks)
08:31AM	Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It? (Zacks)
Dec-09-25 07:28AM	ALGN Stock Rises on Thailand Launch of Invisalign With MAOB (Zacks)
07:27AM	Reasons to Hold Tandem Diabetes Stock in Your Portfolio for Now (Zacks)
07:26AM	RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort (Zacks)
04:49AM	Zacks.com featured highlights include Illumina, Commercial Metals and Newmont (Zacks)
Dec-08-25 10:15AM	Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook (Zacks)
09:45AM	Bet on These 3 Stocks With Upgraded Broker Ratings Amid Uncertainties (Zacks)
07:56AM	PODD Stock Benefits From FDA Approval of Omnipod 5's Enhancements (Zacks)
Dec-05-25 11:30AM	Why Is Acadia (ACAD) Up 22.6% Since Last Earnings Report? (Zacks)
08:48AM	MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System (Zacks)
Dec-04-25 11:30AM	Kymera Therapeutics (KYMR) Up 10.2% Since Last Earnings Report: Can It Continue? (Zacks)
07:20AM	New Strong Buy Stocks for December 4th (Zacks)
Dec-03-25 12:00PM	Illumina (ILMN) Moves to Strong Buy: Rationale Behind the Upgrade (Zacks)
Nov-20-25 04:15PM	Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth (Business Wire)
05:00AM	Roche inks deal for rights to Freenome cancer tests outside US (MedTech Dive)
Nov-19-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Nov-18-25 11:01PM	3 Reasons to Sell ILMN and 1 Stock to Buy Instead (StockStory)
08:48AM	Top 3 Genomics Stocks to Consider for Your Portfolio (Zacks)
Nov-12-25 12:00PM	Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study (PR Newswire)
Nov-11-25 04:05PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
11:40AM	ALKS or ILMN: Which Is the Better Value Stock Right Now? (Zacks)
Nov-10-25 01:31PM	Final Trades: Morgan Stanley, Cisco Systems, Illumina and FTAI Aviation (CNBC TV)
12:15PM	Illumina Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks (PR Newswire)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Davies Scott M	Chief Legal Officer	Dec 12 '25	Sale	136.09	323	43,957	17,887	Dec 16 05:00 PM
SCOTT DAVIES	Officer	Dec 12 '25	Proposed Sale	136.09	323	43,957		Dec 12 04:09 PM
Wedel Christensen Jakob	SVP, Strategy/Corp Development	Dec 08 '25	Sale	129.27	549	70,969	10,952	Dec 09 04:15 PM
JAKOB WEDEL	Officer	Dec 08 '25	Proposed Sale	129.27	549	70,969		Dec 08 04:31 PM
ILLUMINA, INC.	10% Owner	Nov 17 '25	Sale	79.85	1,000,000	79,850,000	3,502,126	Nov 18 09:33 PM
SCOTT DAVIES	Officer	Nov 12 '25	Proposed Sale	122.79	323	39,661		Nov 12 04:05 PM
Gottlieb Scott	Director	Nov 03 '25	Buy	122.13	500	61,065	12,523	Nov 05 04:05 PM
Dhingra Ankur	SVP, Chief Financial Officer	May 12 '25	Buy	81.21	6,100	495,381	24,906	May 14 04:20 PM
Thaysen Jacob	Chief Executive Officer	May 12 '25	Buy	80.88	6,500	525,732	77,540	May 14 04:18 PM
Thaysen Jacob	Chief Executive Officer	May 13 '25	Buy	80.84	5,850	472,942	83,390	May 14 04:18 PM
JAKOB WEDEL CHRISTENSEN	Officer	May 06 '25	Proposed Sale	77.21	549	42,388		May 06 04:02 PM
ARNOLD FRANCES	Director	Feb 27 '25	Proposed Sale	93.48	120	11,218		Feb 27 11:07 AM
JAKOB WEDEL	Officer	Feb 18 '25	Proposed Sale	100.00	460	46,000		Feb 18 04:22 PM
PATRICIA L LECKMAN	Officer	Feb 18 '25	Proposed Sale	100.00	1,756	175,600		Feb 18 04:08 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ILMN

Illumina Inc

Upgrade your FINVIZ experience